Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8
Angiogenesis, the growth OF new capillaries from preexisting blood vessels, is a complex process involving endothelial cell (EC) activation, disruption of vascular basement membranes, and migration and proliferation of ECs. Glycan-mediated recognition has been proposed to play an instrumental role i...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2011
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 16700caa a22017417a 4500 | ||
|---|---|---|---|
| 001 | PAPER-10871 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204057.0 | ||
| 008 | 190411s2011 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-79251573209 | |
| 024 | 7 | |2 cas |a galectin 1, 258495-34-0; galectin 3, 208128-56-7; galectin 8, 220452-97-1; vasculotropin, 127464-60-2; Activated-Leukocyte Cell Adhesion Molecule; Antigens, CD31; Collagen, 9007-34-5; Drug Combinations; Galectins; LGALS8 protein, human; Laminin; Proteoglycans; Recombinant Proteins; Vascular Endothelial Growth Factor A; matrigel, 119978-18-6 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a FAJOE | ||
| 100 | 1 | |a Cárdenas Delgado, V.M. | |
| 245 | 1 | 0 | |a Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8 |
| 260 | |c 2011 | ||
| 270 | 1 | 0 | |m Elola, M. T.; Instituto de Química Y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Junín 956 (C1113), Buenos Aires, Argentina; email: mt_elola@yahoo.com |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Folkman, J., Fundamental concepts of the angiogenic process (2003) Curr. Mol. Med., 3, pp. 643-651 | ||
| 504 | |a Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases (2000) Nature, 407, pp. 249-257 | ||
| 504 | |a Dvorak, H.F., Brown, L.F., Detmar, M., Dvorak, A.M., Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis (1995) Am. J. Pathol., 146, pp. 1029-1039 | ||
| 504 | |a Francis, M.E., Uriel, S., Brey, E.M., Endothelial cell matrix interactions in neovascularization (2008) Tissue Eng. Part B Rev., 14, pp. 19-32 | ||
| 504 | |a Nguyen, M., Eilber, F.R., Defrees, S., Novel synthetic analogs of sialyl Lewis X can inhibit angiogenesis in vitro and in vivo (1996) Biochem. Biophys. Res. Commun., 228, pp. 716-723 | ||
| 504 | |a Nangia-Makker, P., Baccarini, S., Raz, A., Carbohydrate-recognition and angiogenesis (2000) Cancer Metastasis Rev., 19, pp. 51-57 | ||
| 504 | |a Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation (2009) Nat. Rev. Immunol., 9, pp. 338-352 | ||
| 504 | |a Yang, R.Y., Rabinovich, G.A., Liu, F.T., Galectins: Structure, function and therapeutic potential (2008) Expert Rev. Mol. Med., 10, pp. e17 | ||
| 504 | |a Zick, Y., Eisenstein, M., Goren, R.A., Hadari, Y.R., Levy, Y., Ronen, D., Role of galectin-8 as a modulator of cell adhesion and cell growth (2004) Glycoconj. J., 19, pp. 517-526 | ||
| 504 | |a Hadari, Y.R., Paz, K., Dekel, R., Mestrovic, T., Accili, D., Zick, Y., Galectin-8: A new rat lectin, related to galectin-4 (1995) J. Biol. Chem., 270, pp. 3447-3453 | ||
| 504 | |a Su, Z.-Z., Lin, J., Shen, R., Fisher, P.E., Goldstein, N.I., Fisher, P.B., Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 7252-7257 | ||
| 504 | |a Bidon, N., Brichory, F., Bourguet, P., Le Pennec, J.P., Dazord, L., Galectin-8: A complex sub-family of galectins (2001) Int. J. Mol. Med., 8, pp. 245-250 | ||
| 504 | |a Bidon-Wagner, N., Le Pennec, J.P., Human galectin-8 isoforms and cancer (2004) Glycoconj. J., 19, pp. 557-563 | ||
| 504 | |a Ahmed, H., Banerjee, P.P., Vasta, G.R., Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation (2007) Biochem. Biophys. Res. Commun., 358, pp. 241-246 | ||
| 504 | |a Ideo, H., Seko, A., Ishizuka, I., Yamashita, K., The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity (2003) Glycobiology, 13, pp. 713-723 | ||
| 504 | |a Carlsson, S., Oberg, C.T., Carlsson, M.C., Sundin, A., Nilsson, U.J., Smith, D., Cummings, R.D., Leffler, H., Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface (2007) Glycobiology, 17, pp. 663-676 | ||
| 504 | |a Thijssen, V.L., Hulsmans, S., Griffioen, A.W., The galectin profile of the endothelium. Altered expression and localization in activated and tumor endothelial cells (2008) Am. J. Pathol., 172, pp. 545-553 | ||
| 504 | |a Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Raz, A., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am. J. Pathol., 156, pp. 899-909 | ||
| 504 | |a Fukushi, J., Makagiansar, I.T., Stallcup, W.B., NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin (2004) Mol. Biol. Cell, 15, pp. 3580-3590 | ||
| 504 | |a Thijssen, V.L., Postel, R., Brandwijk, R.J.M.G.E., Dings, R.P.M., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 15975-15980 | ||
| 504 | |a Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., Lefranc, F., Knocking down galectin-1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses (2008) J. Neuropathol. Exp. Neurol., 67, pp. 456-469 | ||
| 504 | |a Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Kiss, R., Galectin-1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression (2009) Neoplasia, 11, pp. 485-496 | ||
| 504 | |a Cueni, L.N., Detmar, M., Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions (2009) Exp. Cell Res., 315, pp. 1715-1723 | ||
| 504 | |a (1996) Guide for the Care and Use of Laboratory Animals, , Institute of Laboratory Animal Resources CoLSNRC National Academy Press, Washington, DC, USA | ||
| 504 | |a Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254 | ||
| 504 | |a Aida, Y., Pabst, M.J., Removal of endotoxin from protein solutions by phase separation using Triton X-114 (1990) J. Immunol. Methods, 132, pp. 191-195 | ||
| 504 | |a Nowak, T.P., Haywood, P.L., Barondes, S.H., Developmentally regulated lectin in embryonic chick muscle and a myogenic cell line (1976) Biochem. Biophys. Res. Commun., 68, pp. 650-657 | ||
| 504 | |a Fernández, M.M., Bhattacharya, S., De Marzi, M.C., Brown, P., Kerzick, M., Schuck, P., Mariuzza, R.A., Malchiodi, E.L., Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vβ8.2 (2007) Proteins, 68, pp. 389-402 | ||
| 504 | |a Masedunskas, A., King, J.A., Tan, F., Cochran, R., Stevens, T., Sviridov, D., Ofori-Acquah, S.F., Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration (2006) FEBS Lett., 580, pp. 2637-2645 | ||
| 504 | |a He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab. Invest., 86, pp. 578-590 | ||
| 504 | |a Hadari, Y.R., Arbel-Goren, R., Levy, Y., Amsterdam, A., Alon, R., Zakut, R., Zick, Y., Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis (2000) J. Cell Sci., 113, pp. 2385-2397 | ||
| 504 | |a Levy, Y., Arbel-Goren, R., Hadari, Y.R., Eshhar, S., Ronen, D., Elhanany, E., Geiger, B., Zick, Y., Galectin-8 functions as a matricellular modulator of cell adhesion (2001) J. Biol. Chem., 276, pp. 31285-31295 | ||
| 504 | |a Nishi, N., Shoji, H., Seki, M., Itoh, A., Miyanaka, H., Yuube, K., Hirashima, M., Nakamura, T., Galectin-8 modulates neutrophil function via interaction with integrin M (2003) Glycobiology, 13 (11), pp. 755-763. , DOI 10.1093/glycob/cwg102 | ||
| 504 | |a Cárcamo, C., Pardo, E., Oyanadel, C., Bravo-Zehnder, M., Bull, P., Cáceres, M., Martinez, J., Soza, A., Galectin-8 binds specific β1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells (2006) Exp. Cell Res., 312, pp. 374-386 | ||
| 504 | |a Eshkar Sebban, L., Ronen, Levartovsky, D., Elkayam, O., Caspi, D., Aamar, S., Amital, H., Golan, I., The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation (2007) J. Immunol., 179, pp. 1225-1235 | ||
| 504 | |a Tribulatti, M.V., Cattaneo, V., Hellman, U., Mucci, J., Campetella, O., Galectin-8 provides costimulatory and proliferative signals to T lymphocytes (2009) J. Leukoc. Biol., 86, pp. 1-9 | ||
| 504 | |a He, J., Baum, L.G., Presentation of galectin-1 by extracellular matrix triggers T cell death (2004) J. Biol. Chem., 279, pp. 4705-4712 | ||
| 504 | |a Norling, L.V., Sampaio, A.L.F., Cooper, D., Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking (2008) FASEB Journal, 22 (3), pp. 682-690. , http://www.fasebj.org/cgi/reprint/22/3/682, DOI 10.1096/fj.07-9268com | ||
| 504 | |a Camby, I., Belot, N., Rorive, S., Lefranc, F., Maurage, C.A., Lahm, H., Kaltner, H., Kiss, R., Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration (2001) Brain Pathol., 11, pp. 12-26 | ||
| 504 | |a Elola, M.T., Chiesa, M.E., Fernández Alberti, A., Mordoh, J., Fink, N.E., Galectin-1 receptors in different cell types (2005) J. Biomed. Sci., 12, pp. 13-29 | ||
| 504 | |a Elola, M.T., Wolfenstein-Todel, C., Troncoso, M.F., Vasta, G.R., Rabinovich, G.A., Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival (2007) Cell. Mol. Life Sci., 64, pp. 1679-1700 | ||
| 504 | |a Levy, Y., Ronen, D., Bershadsky, A.D., Zick, Y., Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin (2003) J. Biol. Chem., 278, pp. 14533-14542 | ||
| 504 | |a Ikeda, K., Quertermous, T., Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function (2004) J. Biol. Chem., 279, pp. 55315-55323 | ||
| 504 | |a Ohneda, O., Ohneda, K., Arai, F., Lee, J., Miyamoto, T., Fukushima, Y., Dowbenko, D., Suda, T., ALCAM (CD166): Its role in hematopoietic and endothelial development (2001) Blood, 98, pp. 2134-2142 | ||
| 504 | |a Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J. Exp. Med., 207, pp. 1981-1993 | ||
| 504 | |a Rabinovich, G.A., Cumashi, A., Bianco, G.A., Ciavardelli, D., Iurisci, I., D'Egidio, M., Piccolo, E., Iacobelli, S., Synthetic lactulose amines: Novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology, 16, pp. 210-220 | ||
| 520 | 3 | |a Angiogenesis, the growth OF new capillaries from preexisting blood vessels, is a complex process involving endothelial cell (EC) activation, disruption of vascular basement membranes, and migration and proliferation of ECs. Glycan-mediated recognition has been proposed to play an instrumental role in mediating cell-cell and cell-matrix interactions. Galectins (Gal), a family of glycan-binding proteins with affinity for β-galactosides and a conserved sequence motif, can decipher glycan-containing information and mediate cell-cell communication. Galectin-8 (Gal-8), a member of this family, is a bivalent "tandem-repeat"-type galectin, which possesses 2 CRDs connected by a linker peptide. Here, we show that Gal-8 is endowed with proangiogeneic properties. Functional assays revealed a critical role for this lectin in the regulation of capillary-tube formation and EC migration. Moreover, Matrigel, either supplemented with Gal-8 or vascular endothelial growth factor (VEGF), injected in mice resulted in induction of in vivo angiogenesis. Remarkably, Gal-8 was expressed both in the cytoplasm and nucleus in ECs of normal and tumor vessels. Furthermore, CD166 [activated leukocyte cell adhesion molecule (ALCAM)] was identified as a specific Gal-8-binding partner in normal vascular ECs. Collectively, these data provide the first evidence demonstrating an essential role for Gal-8 in the regulation of angiogenesis with critical implications in tumor biology. © FASEB. |l eng | |
| 593 | |a Instituto de Química Y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Junín 956 (C1113), Buenos Aires, Argentina | ||
| 593 | |a Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni, Universidad de Buenos Aires, Facultad de Farmacia Y Bioquímica, Buenos Aires, Argentina | ||
| 593 | |a Área de Investigación, Instituto de Oncología A. H. Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Departamento de Química Biológica, Facultad de Ciencias Exactas Y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Departamento de Patología, Sanatorio Mater Dei, Buenos Aires, Argentina | ||
| 593 | |a Laboratorio de Inmunopatología, Instituto de Biología Y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CAPILLARY FORMATION |
| 690 | 1 | 0 | |a GLYCAN-BINDING PROTEINS |
| 690 | 1 | 0 | |a INVASION |
| 690 | 1 | 0 | |a ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE |
| 690 | 1 | 0 | |a GALECTIN |
| 690 | 1 | 0 | |a GALECTIN 1 |
| 690 | 1 | 0 | |a GALECTIN 3 |
| 690 | 1 | 0 | |a GALECTIN 8 |
| 690 | 1 | 0 | |a VASCULOTROPIN |
| 690 | 1 | 0 | |a ANGIOGENESIS |
| 690 | 1 | 0 | |a ANIMAL CELL |
| 690 | 1 | 0 | |a ANIMAL EXPERIMENT |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CELL INVASION |
| 690 | 1 | 0 | |a CELL MIGRATION |
| 690 | 1 | 0 | |a CELL NUCLEUS |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a CYTOPLASM |
| 690 | 1 | 0 | |a ENDOTHELIUM CELL |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a MODULATION |
| 690 | 1 | 0 | |a MOUSE |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN BINDING |
| 690 | 1 | 0 | |a PROTEIN DETERMINATION |
| 690 | 1 | 0 | |a PROTEIN EXPRESSION |
| 690 | 1 | 0 | |a TANDEM REPEAT |
| 690 | 1 | 0 | |a ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE |
| 690 | 1 | 0 | |a ANIMALS |
| 690 | 1 | 0 | |a ANTIGENS, CD31 |
| 690 | 1 | 0 | |a CELL LINE |
| 690 | 1 | 0 | |a CELL MOVEMENT |
| 690 | 1 | 0 | |a CELL NUCLEUS |
| 690 | 1 | 0 | |a COLLAGEN |
| 690 | 1 | 0 | |a CYTOPLASM |
| 690 | 1 | 0 | |a DOSE-RESPONSE RELATIONSHIP, DRUG |
| 690 | 1 | 0 | |a DRUG COMBINATIONS |
| 690 | 1 | 0 | |a ENDOTHELIAL CELLS |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a GALECTINS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a IMMUNOBLOTTING |
| 690 | 1 | 0 | |a IMMUNOHISTOCHEMISTRY |
| 690 | 1 | 0 | |a IMMUNOPRECIPITATION |
| 690 | 1 | 0 | |a KINETICS |
| 690 | 1 | 0 | |a LAMININ |
| 690 | 1 | 0 | |a MICE |
| 690 | 1 | 0 | |a MICE, INBRED BALB C |
| 690 | 1 | 0 | |a NEOPLASMS |
| 690 | 1 | 0 | |a NEOVASCULARIZATION, PHYSIOLOGIC |
| 690 | 1 | 0 | |a PROTEIN BINDING |
| 690 | 1 | 0 | |a PROTEOGLYCANS |
| 690 | 1 | 0 | |a RATS |
| 690 | 1 | 0 | |a RECOMBINANT PROTEINS |
| 690 | 1 | 0 | |a VASCULAR ENDOTHELIAL GROWTH FACTOR A |
| 690 | 1 | 0 | |a MUS |
| 700 | 1 | |a Nugnes, L.G. | |
| 700 | 1 | |a Colombo, L.L. | |
| 700 | 1 | |a Troncoso, M.F. | |
| 700 | 1 | |a Fernández, M.M. | |
| 700 | 1 | |a Malchiodi, E.L. | |
| 700 | 1 | |a Frahm, I. | |
| 700 | 1 | |a Croci, D.O. | |
| 700 | 1 | |a Compagno, D. | |
| 700 | 1 | |a Rabinovich, G.A. | |
| 700 | 1 | |a Wolfenstein-Todel, C. | |
| 700 | 1 | |a Elola, M.T. | |
| 773 | 0 | |d 2011 |g v. 25 |h pp. 242-254 |k n. 1 |p FASEB J. |x 08926638 |w (AR-BaUEN)CENRE-996 |t FASEB Journal | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-79251573209&doi=10.1096%2ffj.09-144907&partnerID=40&md5=b09da3d6d2aafb311043c1b540097b74 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1096/fj.09-144907 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_08926638_v25_n1_p242_CardenasDelgado |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08926638_v25_n1_p242_CardenasDelgado |y Registro en la Biblioteca Digital |
| 961 | |a paper_08926638_v25_n1_p242_CardenasDelgado |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||